Skip to main content

Table. 1 Hormone measurements of the patient

From: Characteristics and possible mechanisms of 46, XY differences in sex development caused by novel compound variants in NR5A1 and MAP3K1

Months

LH (mIU/L)

FSH (mIU/L)

T (ng/ml)

E2 (pg/ml)

DHT (pg/ml)

AMH (ng/ml)

T resp. hCG (ng/ml)

DHT resp. hCG (pg/ml)

PRL (ng/ml)

PRG (mg/ml)

3

0.5

4.54

0.1

20

20.66

17.7

–

–

8.93

1.26

4

–

–

0.1

–

33.78

–

0.46

79.23

–

–

9

2.31

12.15

0.93

20

–

–

–

–

13.13

–

  1. AMH anti Müllerian hormone, DHT dihydrotestosterone, E2 estradiol, FSH follicle stimulating hormone, hCG human chorionic gonadotropin, LH luteinizing hormone, PRL prolactin, PRG progesterone, T testosterone